Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Efficacy and Safety Study of 4975 in Patients Undergoing Total Hip Replacement

ClinicalTrials.gov ID: NCT00683267

Public ClinicalTrials.gov record NCT00683267. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 4:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacokinetics of a Single Intraoperative Localized Instillation of 4975 in Patients Undergoing Primary Unilateral Total Hip Arthroplasty

Study identification

NCT ID
NCT00683267
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Anesiva, Inc.
Industry
Enrollment
118 participants

Conditions and interventions

Conditions

Interventions

  • 4975, highly purified capsaicin Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2007
Primary completion
Oct 31, 2008
Completion
Nov 30, 2008
Last update posted
May 3, 2009

2007 – 2008

United States locations

U.S. sites
10
U.S. states
6
U.S. cities
10
Facility City State ZIP Site status
Alabama Clinical Therapeutics, LLC Birmingham Alabama 35235
Lotus Clinical Research, Inc. Arcadia California 91007
Glendale Adventist Medical Center Glendale California 91206
Webster Orthopaedic Medical Group Oakland California 94612
University of California at San Francisco - Mt. Zion San Francisco California 94115
Coastal Medical Research, Inc. Port Orange Florida 32127
William Beaumont Hospital Royal Oak Michigan 48073
William Beaumont Hospital Troy Michigan 48085
Sewickley Valley Hospial Sewickley Pennsylvania 15143
Covenant Medical Center Lubbock Texas 79410

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00683267, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 3, 2009 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00683267 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →